OBJECTIVE: To assess the potential role for Neuregulin-1 (NRG1) as a systemic endogenous protector in the setting of perinatal inflammatory brain damage. METHODS: We measured NRG1-protein and mRNA levels in human umbilical venous endothelial cells (HUVECs) of different gestational ages at various durations of exposure to lipopolysaccharide (LPS). In parallel, we genotyped the donor individuals for SNP8NRG221533, a disease-related single nucleotide polymorphism in the 5' region upstream of the NRG1 sequence. Intracellular NRG1 localization was visualized by confocal microscopy. Furthermore we analyzed the relationship between SNP8NRG221533 genotype and neurodevelopmental outcome in children born preterm. RESULTS: We observed a positive dose-response-relationship between NRG1-mRNA and intracellular protein levels with both advancing gestational age and duration of LPS exposure in HUVECs. The presence of allele C at the SNP8NRG221533 locus was associated with an increased cellular production of NRG1 in HUVECs, and with a significantly reduced risk for cerebral palsy and developmental delay in children born preterm. INTERPRETATION: In conclusion, our data indicate that gestational age, duration of LPS exposure, and the SNP8NRG221533 genotype affect NRG1 levels. Our results support the hypothesis that NRG1 may qualify as an endogenous protector during fetal development. Copyright 2009 Elsevier Inc. All rights reserved.
OBJECTIVE: To assess the potential role for Neuregulin-1 (NRG1) as a systemic endogenous protector in the setting of perinatal inflammatory brain damage. METHODS: We measured NRG1-protein and mRNA levels in human umbilical venous endothelial cells (HUVECs) of different gestational ages at various durations of exposure to lipopolysaccharide (LPS). In parallel, we genotyped the donor individuals for SNP8NRG221533, a disease-related single nucleotide polymorphism in the 5' region upstream of the NRG1 sequence. Intracellular NRG1 localization was visualized by confocal microscopy. Furthermore we analyzed the relationship between SNP8NRG221533 genotype and neurodevelopmental outcome in children born preterm. RESULTS: We observed a positive dose-response-relationship between NRG1-mRNA and intracellular protein levels with both advancing gestational age and duration of LPS exposure in HUVECs. The presence of allele C at the SNP8NRG221533 locus was associated with an increased cellular production of NRG1 in HUVECs, and with a significantly reduced risk for cerebral palsy and developmental delay in children born preterm. INTERPRETATION: In conclusion, our data indicate that gestational age, duration of LPS exposure, and the SNP8NRG221533 genotype affect NRG1 levels. Our results support the hypothesis that NRG1 may qualify as an endogenous protector during fetal development. Copyright 2009 Elsevier Inc. All rights reserved.
Authors: D Zhang; M X Sliwkowski; M Mark; G Frantz; R Akita; Y Sun; K Hillan; C Crowley; J Brush; P J Godowski Journal: Proc Natl Acad Sci U S A Date: 1997-09-02 Impact factor: 11.205
Authors: Josephine Lok; S Pablo Sardi; Shuzhen Guo; Elaine Besancon; Duy M Ha; Anna Rosell; Woo Jean Kim; Gabriel Corfas; Eng H Lo Journal: J Cereb Blood Flow Metab Date: 2008-08-27 Impact factor: 6.200
Authors: D Meyer; T Yamaai; A Garratt; E Riethmacher-Sonnenberg; D Kane; L E Theill; C Birchmeier Journal: Development Date: 1997-09 Impact factor: 6.868
Authors: Abhineet M Sharma; Robert Birkett; Erika T Lin; Linda M Ernst; William A Grobman; Suchitra Swaminathan; Hiam Abdala-Valencia; Alexander V Misharin; Elizabeth T Bartom; Karen K Mestan Journal: JCI Insight Date: 2022-06-08
Authors: Rebecca C Knickmeyer; Jiaping Wang; Hongtu Zhu; Xiujuan Geng; Sandra Woolson; Robert M Hamer; Thomas Konneker; Weili Lin; Martin Styner; John H Gilmore Journal: Cereb Cortex Date: 2013-01-02 Impact factor: 5.357
Authors: Maged M Costantine; Erin A S Clark; Yinglei Lai; Dwight J Rouse; Catherine Y Spong; Brian M Mercer; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Mary J O'Sullivan; Alan M Peaceman; Steve N Caritis Journal: Obstet Gynecol Date: 2012-09 Impact factor: 7.661
Authors: Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer Journal: Glia Date: 2020-11-30 Impact factor: 7.452